Stiefel Laboratories is closing its headquarters in Coral Gables and laying off up to 40 workers. The Stiefel family sold the company to GlaxoSmithKline for $3.6 billion last spring. Some of its employees will be relocating to another Stiefel property in Research Triangle Park. Report
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments